(Q39663417)
Statements
1 reference
A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation (English)
1 reference
Hugh R Wiltshire
1 reference
Gavin J Kilpatrick
1 reference
Gary S Tilbrook
1 reference
Keith M Borkett
1 reference
16 January 2012
1 reference
1 reference
115
1 reference
2
1 reference
284-296
1 reference
Identifiers
1 reference
1 reference